James Robinson (biopharmacist)
James (Jim) Robinson is the vice chair of the Coalition for Epidemic Preparedness Innovations (CEPI).
James Robinson | |
|---|---|
| Scientific career | |
| Institutions | G.D. Searle, LLC Sanofi Pasteur Novavax Merck Coalition for Epidemic Preparedness Innovations (CEPI) |
Robinson manages the CEPI manufacturing stategy for a COVID-19 vaccine.[1]
Career
Robinson began his career as a biochemical engineer with G.D. Searle and worked at various companies before becoming the head of technical support for Merck's vaccine, biologics and sterile manufacturing in 2010.[2][3]
In 2017, Robinson began serving on CEPI's scientific advisory board. He was made vice-chair in 2019.[3]
gollark: ```I think you shouldn't already be banning people if you haven't worked out a set of rules.```
gollark: There wouldn't *be* a time if it was just that ones older than a year simply weren't considered.
gollark: What do you want to say exactly?
gollark: It'd make sense.
gollark: Maybe things older than a year are dropped off?
References
- Heath, Elizabeth Weise and David (26 April 2020). "'Our moon shot': The world needs a coronavirus vaccine ASAP. Despite drugmakers billion-dollar bets, one might not be available for years". USA TODAY. Retrieved 2020-05-20.
- Dumiak, Michael (2017). "A Crisis Gives You WIngs". IAVI Report. Retrieved 2020-05-20.
- Wright, Rob (27 March 2020). "The Little-Known Coalition Tasked With Saving The World From COVID-19". Life Science Leader. Retrieved 2020-05-20.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.